HCLSIG/PharmaOntology/Meetings/2010-07-01 Conference Call

Conference Details

* Date of Call: Thursday July 1 2010 
* Time of Call: 12:00pm - 1:00pm ET 
* Dial-In #: +1.617.761.6200 (Cambridge, MA) 
* Dial-In #: +33.4.89.06.34.99 (Nice, France) 
* Dial-In #: +44.117.370.6152 (Bristol, UK) 
* Participant Access Code: 42572 ("HCLS2") 
* IRC Channel: irc.w3.org port 6665 channel #HCLS2 (see W3C IRC page for details, or see Web IRC) 
* Mibbit quick start: Click on mibbit for instant IRC access
* Duration: 1h 
* Convener: Susie

Agenda

Next Steps/Strategy Discussion - Susie
TMO Updates - Michel, Elgar
Patient Mapping - Michel, Chime, EricP
Interface/eMerge - Bosse, Chris
Outreach (UPenn Translational Medicine, AMIA 2011 Summit on Translational Bioinformatics, etc.) - All
AOB

Minutes

Attendees: Bob, EricP, Julia, Elgar, Joanne, Bosse, Trish, Chris, Christi, Susie

<Bob> Susie: Strategy and next steps

<Bob> ...EHR work should be tied closely to Terminology
<Bob> ...if Conor has bandwidth then we can work with
<Bob> ...Cannot control how collaboration progresses w Marshfield, depends on Luke
<Bob> ...Growing interest in group in research side
<Susie> http://esw.w3.org/HCLSIG/PharmaOntology/UseCases
<Bob> ...Where should efforts go?  How similar animal models are to human models
<Bob> ...Make sure that we have broad level of mapping
<Bob> ...Also broad scenario integrative use cases 
<Bob> ...These have been some of the broad areas in which we could focus
<Bob> ...Other insights for extending demo?
<Bob> Joanne: Meeting last night, Collaborative Care Tech Working Group
<Bob> ...Cost containment, care coordination; group is just starting up
<Bob> ...Harvard Med dean was there, etc.
<Bob> ...Summary w legislation just passed
<Bob> ...Maybe we could integrate with these people
<Bob> ...Might be a great opportunity to guide them into semantic tech
<Julia> http://cctwg.eventbrite.com/ - this is the website I found
<Bob> ...CCTWG not accepting corporate money, focus on bringing new tech to market
<Bob> Susie: Discuss next week?
<Bob> ...Is there a research component to this group?
<Bob> Joanne: This is part of the bigger picture, maybe we can get them on a call.
<Bob> ...Limiting to 30 to make sure that something gets done; criteria-based, really good
<Bob> Susie: Let's look at this week, see if we can invite them to give a talk.
<Bob> Have patient data in CHI(?)
<Bob> Susie: TMO has decided to use artificial patient data, b/c of legal conflicts
<Bob> ...Legal exposure is serious
<Bob> Eric: Certainly Indivo folks are interested in our artificial data
<Bob> Susie: Peter Tonelleto helped us by pointing to fields for artificial patient data, at a high level
<Bob> Joanne: He creates distribution of data, etc
<ericP> ericP: spoke with Ben Adida about Indivo
<ericP> ... He thinks of the data as RDF as he created XML schemas.
<ericP> ... In my survey, I think it lacks some details for coding our tests.
<ericP> ... Ben's anxious to use our fabricated patients
<ericP> ... Liked the idea of then GRDDLing it back to TMO
<ericP> ... this is sort of extra work for us, but could give us real data later
<ericP> ... also gives us a good sanity check
<Bob> Eric: Spoke w Ben, likely to be little impedance mismatch in going to RDF
<Bob> ...They lack details for coding our data
<Bob> Susie: Chime has comments about how schema would have to be modified
<Bob> Eric: If we express our patients in Indivo, followed by grrdl, then he was interested
<Bob> Susie: Interested in using Chime's patient records
<Bob> ...Want to make Indivo data compatible w. CPR
<Bob> Eric: If we can look at Chime's schema and say it's what we ultimately want; then pieces not in there are interesting to Ben
<Bob> ...Would be deployed patient record schema that is normative in RDF
<Bob> ...I talked to him when he had time
<Bob> Susie: He would like concrete suggestions
<Bob> Chris: Marshfield, Scott, Conor is going forward a bit more
<Bob> Show how our tools are relevant; will have an outline to you in a week or two
<Bob> Highlight most important things for the real world.
<Bob> Christi: Voice some support more into early research; linkage back to early research is where my company is coming from
<Bob> Joanne: That component is essential, we must use both
<Bob> Christi: Have people looked through the use cases on the wiki pages?
<Bob> Joanne: Last night's group might resonate with us, for global impact
<Bob> Try to get something to show how works in real world.
<Bob> Christi: Look at wiki for next week?
<Bob> Trish: How many people next week?
<Bob> ...Reviewing Joanne's group, plus looking at wiki are good action items